Ahead of World AIDS Day, Uganda is recruiting women to participate in a trial of an injectable antiretroviral drug to replace Truvada, a daily pill that has low adherence by users. The trial will assess if the new drug – Cabotegravir – can further reduce the risk of acquiring HIV. Halima Athumani has more from Kampala.
…
your ad here
